The online version of this article (doi:10.1186/1471-2261-14-177) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interest.
BT has conducted the study. BT, MA, ZA and NM contributed to the design of the study, participated in the data analysis and interpretation. BT and NM prepared the manuscript. All authors participated in the manuscript writing and approved the final version.
Data is sparse concerning the magnitude of metabolic syndrome (MetS) in developing countries like Ethiopia whose major health problem had long been under-nutrition and infectious diseases rather than non-communicable diseases (NCDs) including hypertension, obesity and MetS. However, it is obvious that the NCDs are recently taking over and becoming the major health care concerns in the developing countries. This pattern could be partly explained by the nation’s sustained economical growth in the last few decades in addition to the increasing globalization related adoption of western lifestyle. The aim of this study was to assess the prevalence of metabolic syndrome and associated factors among hypertensive patients in North West Ethiopia.
A cross sectional study was conducted on 300 hypertensive individuals who get follow-up care at University of Gondar Hospital after diagnosed as hypertensive. The WHO STEP-wise approach to surveillance of NCD was used. Fasting blood glucose level, triglyceride and high density lipoprotein cholesterol were determined using standardized laboratory procedures.
The prevalence of metabolic syndrome was 40.7% and 39.3% according to the modified NCEP-ATP III and IDF criteria respectively. Low HDL-c was found to be the most frequently encountered (81.3%) component of MetS other than the hypertension. Being female was significantly associated with MetS (AOR = 4.34; 95% CI: 2.09, 8.99) using IDF and (AOR = 3.30; 95% CI: 1.66, 6.58) using NCEP-ATP III criteria. Abnormal BMI which included both high and low BMI was found to have significant association with MetS (AOR = 3.10; 95% CI: 1.73, 5.58) using IDF and (AOR = 1.84; 95% CI: 1.05, 3.22) as diagnosed using the NCEP-ATP III criteria.
We recommend a comprehensive medical care approach to hypertensive patients to adequately assess and address the additional components of MetS which are known to potentiate the risks of cardiovascular diseases among hypertensive patients.
World Health Organization (WHO): Non-Communicable Diseases Country Profile. 2011
International diabetes federation (IDF): The IDF consensus worldwide definition of the metabolic syndrome. 2006, http://www.idf.org/webdata/docs/MetS_def_update2006.pdf,
Osuji CU, Omejua EG: Prevalence and characteristics of the metabolic syndrome among newly diagnosed hypertensive patients. Indian J Endocrinol Metab. 2012, 16: 104-109. 10.4103/2230-8210.94256. CrossRef
Marchi-Alves LM, Rigotti AR, Nogueira MS, Cesarino CB, de Godoy S: Metabolic syndrome components in arterial hypertension. S Rev Esc Enferm USP. 2012, 46: 1348-1353. 10.1590/S0080-62342012000600010. CrossRef
Hsu CN, Chen YC, Wang TD: Prevalence and characteristics of the metabolic syndrome in Chinese hypertensive patients: a hospital-based observation. Acta Cardiol Sin. 2005, 21: 89-97.
Tran A, Gelaye B, Girma B, Lemma S, Berhane Y, Bekele T, Khali A, Williams MA: Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens. 2011, doi:10.4061/2011/193719
Su CH, Fang CY, Chen JS, Po HL, Chou LP, Chiang CY, Ueng KC: Prevalence of metabolic syndrome and its relationship with cardiovascular disease among hypertensive patients 55-80 years of age. Acta Cardiol Sin. 2011, 27: 229-237.
World Health Organization (WHO): Chronic diseases and health promotion: Stepwise approach to surveillance (STEPS). 2010, http://www.who.int/chp/steps/instrument/STEPS_Instrument_V3.1.pdf,
Lemogoum D, Seedat YK, Mabadeje AF, Mendis S, Bovet P, Onwubere B, Blackett KN, Lenfant C, Kabangu JR, Block P, Belhocine M, Degaute JP: Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. J Hypertens. 2003, 21: 1993-2000. 10.1097/00004872-200311000-00003. CrossRefPubMed
Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM: Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diab Care. 2004, 27: 2676-2681. 10.2337/diacare.27.11.2676. CrossRef
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644. CrossRefPubMed
Ogbu ISI, Ugwuja EI: Metabolic syndrome in hypertensive nigerians: risk factor analysis. IOSR J Pharm Biol Sci. 2012, 4: 28-32.
Yasein N, Ahmad M, Matrook F, Nasir L, Froelicher ES: Metabolic syndrome in patients with hypertension attending a family practice clinic in Jordan. East Mediterr Health J. 2010, 16: 375-380. PubMed
Shahbazian H, Latifi SM, Jalali MT, Shahbazian H, Amani R, Nikhoo A, Aleali AM: Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diab Metab Disord. 2013, 12: 11-10.1186/2251-6581-12-11. CrossRef
- Metabolic syndrome among hypertensive patients at University of Gondar Hospital, North West Ethiopia: a cross sectional study
- BioMed Central
Neu im Fachgebiet Kardiologie
Mail Icon II